52
https://pubmed.ncbi.nlm.nih.gov/38117454
The study finds that decreased ZMIZ1, associated with vitiligo, inhibits melanin production in vitro by regulating mTOR/AKT/GSK-3β-mediated glucose uptake, suggesting a potential therapeutic target.